Rodríguez VAJ, Jiménez HBA, González RLO, Santos HJE, Contreras CTIF, Acosta RCQ

Language: Spanish
References: 14
Page: 181-184
PDF size: 157.85 Kb.

ABSTRACT

Rickettsiosis are diseases of worldwide distribution capable of producing severe and lethal conditions in the population, with mortality rates that reach up to 30% in pediatric patients. They are produced by obligate intracellular gram-negative coccobacilli, which have an animal reservoir and an arthropod vector such as ticks. The clinical picture is characterized by high-grade fever, rash, myalgia, arthralgia, headache, and general malaise. The diagnosis is mainly clinical confirmed by serology, immunofluorescence or PCR. The treatment of choice is tetracyclines. We present a 14-year-old patient with general malaise, high-grade fever, headache, myalgia, arthralgia and a 10-day-old rash with negative serology for dengue, a history of close contact with ticks, suspected of probable rickettsiosis at least. Who received specific treatment with doxycycline presenting a favorable clinical evolution.

REFERENCES

1. “Guía de práctica clínica. Prevención, diagnóstico y tratamientode la fiebre manchada por Rickettsia rickettsii,en población pediátrica y adulta en el primer y segundonivel de atención”, México, Secretaría de Salud, 2013.

2. Sistema Nacional de Vigilancia Epidemiológica, SistemaÚnico de Información, “Boletín epidemiológico2021”. Disponible en: https://www.gob.mx/salud/documentos/boletinepidemiologico-sistema-nacional-de-vigilancia-epidemiologica-sistema-unico-de-informacion-231750.

3. Oteo, J.A., Nava, S., De Sousa, R., Mattar, S., Venzal,J.M., Abarca, K. y Zavala-Castro, J., “Guías latinoamericanasde la riicer para el diagnóstico de las rickettsiosistransmitidas por garrapatas”, Revista Chilena de Infectología2014; 31 (1): 54-65.

4. Murray, P., Rosenthal, K. y Pfaller, M., Microbiología médica,Madrid, Elsevier, 7ª ed., 2014.

5. Blanton, L.S., “The rickettsioses”, Infectious Disease Clinicsof North America, 2019, 33 (1): 213-229.

6. Biggs, H.M., Behravesh, C.B., Bradley, K.K., Dahlgren,F.S. et al., “Diagnosis and management of tickbornerickettsial diseases: rocky mountain spotted fever andother spotted fever group rickettsioses, ehrlichioses,and anaplasmosis United States”, mmwr Recomm Rep2016; 65 (2): 1-44.

7. Centers for Disease Control and Prevention (cdc), Rickettsiosis,National Center for Emerging and Zoonotic InfectiousDiseases (ncezid), Division of Vector-Borne Diseases(dvbd), enero de 2019. Disponible en: https://www.cdc.gov/ticks/tickbornediseases/rickettsiosis.html.

8. Sekeyová, Z., Danchenko, M., Filipčík, P. y Fournier, P.E.,Rickettsial infections of the central nervous system”, plosNeglected Tropical Diseases 2019; 13 (8): e0007469.

9. Mandell, G., Bennett, J. y Dolin, R., Enfermedades infecciosas,principios y prácticas, Madrid, Elsevier, 2020.

10. Minervino, A.H.H., Labruna, M.B., Dias, S.R., Costa, F.B.,Martins, T.F., Da Silva, P.N.S. y Faccini-Martínez, Á.A.,“Typhus Group Rickettsiosis, Brazilian Amazon”, EmergInfect Dis. 2020;26(9):2294-2296.

11. Kulkarni, A., “Childhood Rickettsiosis”. Indian J Pediatr2010; 78 (1): 81-87.

12. Fang, R., Blanton, L. y Walker, D., “Rickettsiae as emerginginfectious agents”, Clinics in Labortory Medicine,2017; 37 (2): 383-400.

13. Todd, S.R., Dahlgren, F.S., Traeger, M.S. et al., “No visibledental staining in children treated with doxycyclinefor suspected Rocky Mountain Spotted Fever”, J Pediatr,2015; 166: 1246.

14. Delgado-De la Mora, J., Licona-Enríquez, J.D., Candia-Plata, M.C. y Álvarez-Hernández, G., “Discusión defactores pronóstico en dos casos familiares de fiebremanchada de las Montañas Rocosas”. Acta Pediatr Mex2018; 39 (4): 323-327.